Tarsus Pharmaceuticals In... (TARS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

52.50

-0.23%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	17.45M	25.82M	57.03M	-	-	-
Cost of Revenue	1.59M	955.00K	2.08M	246.00K	74.00K	1K
Gross Profit	15.85M	24.86M	54.95M	-246.00K	-74.00K	-1K
Operating Income	-143.16M	-62.71M	-12.16M	-27.00M	-4.30M	-1.35M
Interest Income	10.34M	3.50M	36.00K	188.00K	40.00K	-
Pretax Income	-135.89M	-62.09M	-13.77M	-26.81M	-4.67M	-1.32M
Net Income	-135.89M	-62.09M	-13.83M	-26.81M	-4.67M	-1.32M
Selling & General & Admin	108.70M	44.95M	25.40M	8.17M	1.14M	449.00K
Research & Development	50.31M	42.62M	41.71M	18.83M	3.16M	901.00K
Other Expenses	-	86.00K	-73.00K	-	-	-
Operating Expenses	159.01M	87.57M	67.11M	27.00M	4.30M	1.35M
Interest Expense	3.35M	2.20M	-	188.00K	40.00K	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	160.60M	88.53M	69.18M	27.00M	4.30M	1.35M
Income Tax	-	-4.00K	55.00K	1K	1K	1K
Shares Outstanding (Basic)	29.38M	24.62M	20.55M	20.32M	19.51M	4.29M
Shares Outstanding (Diluted)	29.38M	24.62M	20.55M	20.32M	19.51M	4.29M
EPS (Basic)	-4.62	-2.52	-0.67	-1.32	-0.24	-0.31
EPS (Diluted)	-4.62	-2.52	-0.67	-1.32	-0.24	-0.31
EBITDA	-131.67M	-59.11M	-13.17M	-26.56M	-4.55M	-1.35M
Depreciation & Amortization	877.00K	789.00K	606.00K	246.00K	74.00K	1K